The evolution of in vitro fertilization: Integration of pharmacology, technology, and clinical care

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 3, 2005, Pages 935-942

  Feinberg, Eve C ^a,b   Bromer, Jason G ^a,c   Catherino, William H ^a,b,d  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d Building A ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABARELIX; BUSERELIN; CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GANIRELIX; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; GOSERELIN; HUMAN MENOPAUSAL GONADOTROPIN; HYPOPHYSIS EXTRACT; ITURELIX; LEUPRORELIN; MERIONAL; NAFARELIN ACETATE; NAL GLU; NOVAREL; ORAL CONTRACEPTIVE AGENT; ORGAFOL; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT HORMONE; RECOMBINANT LUTEINIZING HORMONE; TEVERELIX; TRIPTORELIN; UNCLASSIFIED DRUG; UROFOLLITROPIN; UTROGEST;

ANAPHYLAXIS; CLINICAL TRIAL; CREUTZFELDT JAKOB DISEASE; DRUG COST; EGG PRODUCTION; FERTILIZATION IN VITRO; HOT FLUSH; HUMAN; INFERTILITY; INJECTION SITE REACTION; INTRACYTOPLASMIC SPERM INJECTION; MENSTRUAL CYCLE; META ANALYSIS; NIDATION; NONHUMAN; OOCYTE; OVARY; OVARY HYPERSTIMULATION; PATIENT CARE; PHARMACOLOGICAL SCIENCE; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW;

CHORIONIC GONADOTROPIN; CLOMIPHENE; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; MENSTRUAL CYCLE; PROGESTERONE;

EID: 19444384432     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.080051     Document Type: Review

References (62)

1. Akande V, Fleming C, Hunt L, Keay S, and Jenkins J (2002) Biological vs. chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod 17:2003-2008.
2. Araujo E Jr, Bernardini L, Frederick JL, Asch RH, and Balmaceda JP (1994) Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction. J Assist Reprod Genet 11:74-78.
3. Avecillas JF, Falcone T, and Arroliga AC (2004) Ovarian hyperstimulation syndrome. Crit Care Clin 20:679-695.
4. Baird D and Glasier A (1993) Hormonal contraception. New Engl J Med 328:1543-1549.
5. Belchetz PE, Plant TM, Nakai Y, Keogh EJ, and Knobil E (1978) Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science (Wash DC) 202:631-633.
6. Burkman R, Schlesselman J, and Zieman M (2004) Safety concerns and health benefits associated with oral contraceptives. Am J Obstet Gynecol 190:S5-22.
7. Burmeister L, Palermo GD, and Rosenwaks Z (2001) IVF: the new era. Int J Fertil Womens Med 46:137-144.
8. Coccia M, Comparetto C, and Bracco G (2004) GnRH antagonists. Eur J Obstet Gynecol Reprod Biol 115 (Suppl):S44-S56.
9. Cochius JI, Burns RJ, Blumbergs PC, Mack K, and Alderman CP (1990) Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust N Z J Med 20:592-593.
10. Crowe S, Cushing H, and Homans J (1910) Experimental hypophysectomy. Bull Johns Hospital 21:127-167.
11. Daya S (2002) Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertil Steril 77:711-714.
12. Derman SG and Seifer DB (2003) In vitro fertilization in the older patient. Curr Womens Health Rep 3:375-383.
13. Dickey RP and Holtkamp DE (1996) Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update 2:483-506.
14. Donini P, Puzzuoli D, and D'Alessio I (1964) Purification of gonadotrophin from menopausal urine by gel filtration on sephadex. Acta Endocrinol (Copenh) 45:329-334.
15. Donini P, Puzzuoli D, D'Alessio I, Lunenfeld B, Eshkol A, and Parlow AF (1966a) Purification and separation of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from human postmenopausal gonadotrophin (HMG). I. Separation of FSH and LH by electrophoresis, chromatography and gel filtration procedures. Acta Endocrinol (Copenh) 52:169-185.
16. Donini P, Puzzuoli D, D'Alessio I, Lunenfeld B, Eshkol A, and Parlow AF (1966b) Purification and separation of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from human postmenopausal gonadotrophin (HMG). II. Preparation of biological apparently pure FSH by selective binding of the LH with an anti-HGG serum and subsequent chromatography. Acta Endocrinol (Copenh) 52:186-198.
17. Edwards RG, Steptoe PC, and Purdy JM (1980) Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynaecol 87:737-756.
18. Eshkol A and Lunenfeld B (1967) Purification and separation of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from human menopausal gonadotrophin (HMG), 3. Effects of a biologically apparently pure FSH preparation on ovaries and uteri of intact, immature mice. Acta Endocrinol (Copenh) 54:91-95.
19. Fasouliotis S, Laufer N, Sabbagh-Erlich S, Lewin A, Hurwitz A, and Simon A (2003) GnRH antagonist vs. GnRH agonist in ovarian stimulation of poor responders undergoing IVF. J Assist Reprod Genet 20:455-460.
20. Flouret G, Mahan K, and Majewski T (1992) Decreased histamine release by luteinizing hormone releasing hormone antagonists obtained upon translocation of the cationic amino acid from position 8 to position 7. J Med Chem 35:636-640.
21. Fluker M, Grifo J, Leader A, Levy M, Meldrum D, Muasher SJ, Rinehart J, Rosenwaks Z, Scott RT Jr, Schoolcraft W, et al. (2001) Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 75:38-45.
22. Frydman R, Forman R, Rainhorn JD, Belaisch-Allart J, Hazout A, and Testart J (1986) A new approach to follicular stimulation for in vitro fertilization: programed oocyte retrieval. Fertil Steril 46:657-662.
23. Fuller B and Paynter S (2004) Fundamentals of cryobiology in reproductive medicine. Reprod Biomed Online 9:680-691.
24. Gemzell C (1965) Induction of ovulation with human gonadotropins. Recent Prog Horm Res 21:179-204.
25. Gemzell CA, Diczfalusy E, and Tillinger G (1958) Clinical effect of human pituitary follicle-stimulating hormone (FSH). J Clin Endocrinol Metab 18:1333-1348.
26. Genbacev OD, Prakobphol A, Foulk RA, Krtolica AR, Ilic D, Singer MS, Yang ZQ, Kiessling LL, Rosen SD, and Fisher SJ (2003) Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface. Science (Wash DC) 299:405-408.
27. Gurin S, Bachman G, and Wilson D (1940) The gonadotropic hormone of urine of pregnancy. II. Chemical studies of preparations having high biological activity. J Biol Chem:467-470.
28. Hamblen E (1939) Clinical evaluation of ovarian responses to gonadotropic therapy. Endocrinology 24:848-857.
29. Hillier SG, Afnan AM, Margara RA, and Winston RM (1985) Superovulation strategy before in vitro fertilization. Clin Obstet Gynaecol 12:687-723.
30. Hofman G, Soshowski J, Scott R, and Thie J (1996) Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population. Fertil Steril 66:49-53.
31. Jungck EC and Brown WE (1952) Human pituitary gonadotropin for clinical use preparation and lack of antihormone formation. Fertil Steril 3:224-229.
32. Lewis S and Klonoff-Cohen H (2005) What factors affect intracytoplasmic sperm injection outcomes? Obstet Gynecol Surv 60:111-123.
33. Ljungqvist A, Feng DM, Tang PFL, Kubota M, Okamoto T, Zhang Y, Bowers CY, Hook WA, and Folkers K (1987) Design, synthesis and bioassays of antagonists of LHRH which have high antiovulatory activity and release negligible histamine. Biochem Biophys Res Commun 148:849-856.
34. Loutradis D, Stefanidis K, Drakakis P, Milingos S, Antsaklis A, and Michalag S (2004) A modified gonadotropin releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol. Fertil Steril 82:1446-1448.
35. Ludwig M and Diedrich K (2001) Evaluation of an optimal luteal phase support protocol in IVF. Acta Obstet Gynecol Scand 80:452-466.
36. Macklon NS and Fauser BC (2000) Impact of ovarian hyperstimulation on the luteal phase. J Reprod Fertil Suppl 55:101-108.
37. Maddock WO, Leach RB, Tokuyama I, Paulsen CA, and Roy WR (1956) Effects of hog pituitary follicle-stimulating hormone in women: antihormone formation and inhibition of ovarian function. J Clin Endocrinol Metab 16:433-448.
38. Meldrum DR, Chang RJ, Lu J, Vale W, Rivier J, and Judd HL (1982) "Medical oophorectomy" using a long-acting GNRH agonist - a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 54:1081-1083.
39. Meldrum DR, Rivier J, Garzo G, Wisot A, Stubbs C, and Hamilton F (1994) Successful pregnancies with unstimulated cycle oocyte donation using an antagonist of gonadotropin-releasing hormone. Fertil Steril 61:556-557.
40. Mishell DJ, Kletzky O, and Brenner P (1972) The effect of contraceptive steroids on hypothalamic-pituitary function. Am J Obstet Gynecol 130:817.
41. Neuwirth RS, Todd WD, Turksoy RN, and Vandewiele RL (1965) Successful quadruplet pregnancy in a patient treated with human menopausal gonadotropins. Am J Obstet Gynecol 91:982-984.
42. Nicopoullos JD, Ramsay JW, Almeida PA, and Gilling-Smith C (2004) Assisted reproduction in the azoospermic couple. BJOG 111:1190-1203.
43. Palter S and Olive D (1996) Reproductive Physiology. Williams and Wilkins, Baltimore.
44. Pasetto N and Montanino G (1967) Pregnancy after combined HMG-HCG treatment in amenorrheic patients. Fertil Steril 18:685-693.
45. Patton PE, Burry KA, Wolf DP, Kiessling AA, and Craemer MJ (1988) The use of oral contraceptives to regulate oocyte retrieval. Fertil Steril 49:716-718.
46. Penzias AS (2002) Luteal phase support. Fertil Steril 77:318-323.
47. Periti P, Mazzei T, and Mini E (2002) Clinical pharmacokinetics of depot leuprorelin. Clin Pharmacokinet 41:485-504.
48. Pimstone B, Epstein S, Hamilton SM, LeRoith D, and Hendricks S (1977) Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure. J Clin Endocrinol Metab 44:356-360.
49. Porter RN, Smith W, Craft IL, Abdulwahid NA, and Jacobs HS (1984) Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 2:1284-1285.
50. Pritts EA and Atwood AK (2002) Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 17:2287-2299.
51. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M, and Fisher SJ (2004) Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Investig 114:744-754.
52. Schally AV, Baba Y, Nair RM, and Bennett CD (1971) The amino acid sequence of a peptide with growth hormone-releasing activity isolated from porcine hypothalamus. J Biol Chem 246:6647-6650.
53. Seegar-Jones G, Gey G, and Ghisletta M (1943) Hormone production by placental cells maintained in continuous culture. Bull Johns Hospital 26-38.
54. Sermon K, Van Steirteghem A, and Liebaers I (2004) Preimplantation genetic diagnosis. Lancet 363:1633-1641.
55. Soliman S, Daya S, Collins J, and Hughes EG (1994) The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 61:1068-1076.
56. Steptoe PC and Edwards RG (1976) Reimplantation of a human embryo with subsequent tubal pregnancy. Lancet 1:880-882.
57. Strott C, Yoshimi T, Ross G, and Lipsett M (1969) Ovarian physiology: relationship between plasma LH and steroidogenesis by the follicle and corpus luteum; effect of HCG. J Clin Endocrinol Metab 29:1157-1167.
58. Summers MC and Biggers JD (2003) Chemically defined media and the culture of mammalian preimplantation embryos: historical perspective and current issues. Hum Reprod Update 9:557-582.
59. Tietze C (1957) Reproductive span and rate of reproduction among Hutterite women. Fertil Steril 8:89-91.
60. Toner J, Philput C, Jones G, and Muasher S (1991) Basal follicle-stimulating hormone is a better predictor of in-vitro fertilization performance than age. Fertil Steril 55:784-791.
61. Wildt L, Diedrich K, van der Ven H, al Hasani S, Hubner H, and Klasen R (1986) Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins. Hum Reprod 1:15-19.
62. Yen SS (1983) Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Fertil Steril 39:257-266.